Clal Biotechnology Industries Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
2
- Investments
-
65
- Portfolio
-
3
- Exits
-
29
Clal Biotechnology Industries General Information
Company Description
Founded in 1993, Clal Biotechnology Industries is a venture capital investment firm based in Tel Aviv, Israel. The firm prefers to invest in companies operating in the biotech, pharma, diagnostics, and medical devices sectors. The firm prefers to invest in companies based in Israel and the United States.
Business Details
Investor Status
Primary Investor Type
Other Investor Types
Corporate Office
- Triangle Building 45th floor
- Azrieli Center
- Tel Aviv 67023
- Israel
Clal Biotechnology Industries Investments (65)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| eXIthera Pharmaceuticals | 01-Jul-2022 | Later Stage VC | Drug Discovery | Clinical Trials - Phase 1 | ||
| Elicio Therapeutics | 17-Feb-2021 | Drug Discovery | Generating Revenue | |||
| Sight Diagnostics | 01-Jul-2020 | Diagnostic Equipment | Generating Revenue | |||
| Cadent Therapeutics | 29-Apr-2020 | Drug Discovery | Clinical Trials - Phase 2 | |||
| Pi-Cardia | 20-Apr-2020 | Surgical Devices | Generating Revenue | |||
| MinInvasive | 22-Oct-2019 | Other Devices and Supplies | Out of Business | |||
| Elicio Therapeutics | 01-Apr-2019 | Drug Discovery | Generating Revenue | |||
| Sight Diagnostics | 14-Feb-2019 | Diagnostic Equipment | Generating Revenue | |||
| MinInvasive | 02-Oct-2018 | Later Stage VC | Other Devices and Supplies | Out of Business | ||
| Colospan | 24-Sep-2017 | Later Stage VC | Surgical Devices | Clinical Trials - General |
Clal Biotechnology Industries Exits (29)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Colospan | 22-Jun-2026 | Merger/Acquisition | |
| eXIthera Pharmaceuticals | 15-Sep-2025 | ||
| VacciGuard | 19-Nov-2024 | ||
| Gamida Cell | 13-May-2024 | ||
| Elicio Therapeutics | 01-Jun-2023 | ||
| MinInvasive | 01-Mar-2023 | ||
| Cadent Therapeutics | 31-Mar-2021 | ||
| Anchiano Therapeutics | 16-Mar-2021 | ||
| Gamida Cell | 28-Jun-2019 | Public Investment 2nd Offering | |
| Gamida Cell | 26-Oct-2018 | IPO |
Clal Biotechnology Industries Investments by Industry, Year, and Region
Clal Biotechnology Industries Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Biomedical Investments | Tel Aviv, Israel | 1997 |
Clal Biotechnology Industries FAQs
-
What is Clal Biotechnology Industries?
Founded in 1993, Clal Biotechnology Industries is a venture capital investment firm based in Tel Aviv, Israel.
-
When was Clal Biotechnology Industries founded?
Clal Biotechnology Industries was founded in 1993.
-
Where is Clal Biotechnology Industries headquartered?
Clal Biotechnology Industries is headquartered in Tel Aviv, Israel.
-
How many investments has Clal Biotechnology Industries made?
Clal Biotechnology Industries has made 65 investments.
-
What has Clal Biotechnology Industries invested in?
Clal Biotechnology Industries has made numerous investments in companies like eXIthera Pharmaceuticals, Elicio Therapeutics, and Sight Diagnostics within the Drug Discovery and Diagnostic Equipment industries.
-
What has Clal Biotechnology Industries invested in recently?
Clal Biotechnology Industries's latest investment was on 01-Jul-2022 in eXIthera Pharmaceuticals, a company within the Drug Discovery industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process